Myfortic (mycophenolate sodium) delayed-release tablets

Dermatol Online J. 2008 Aug 15;14(8):4.

Abstract

Myfortic is a new formulation of mycophenolic acid (MPA) utilizing enteric coated mycophenolate sodium (EC-MPS) that may have fewer gastrointestinal side effects.

Publication types

  • Review

MeSH terms

  • Abnormalities, Drug-Induced / etiology
  • Abortion, Spontaneous / chemically induced
  • Contraindications
  • Delayed-Action Preparations
  • Female
  • Gastric Acid
  • Humans
  • Hydrogen-Ion Concentration
  • IMP Dehydrogenase / antagonists & inhibitors
  • Immunosuppressive Agents / administration & dosage*
  • Immunosuppressive Agents / pharmacokinetics
  • Intestinal Absorption
  • Male
  • Mycophenolic Acid / administration & dosage*
  • Mycophenolic Acid / analogs & derivatives
  • Mycophenolic Acid / pharmacokinetics
  • Pregnancy
  • Prodrugs / pharmacokinetics
  • Skin Diseases / drug therapy
  • Tablets, Enteric-Coated

Substances

  • Delayed-Action Preparations
  • Immunosuppressive Agents
  • Prodrugs
  • Tablets, Enteric-Coated
  • IMP Dehydrogenase
  • Mycophenolic Acid